Peregrine Pharmaceuticals reported $10M in Trade Creditors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acceleron Pharma XLRN:US $ 5.09M 4.35M
Adamas Pharmaceuticals ADMS:US 4.21M 1.74M
Amgen AMGN:US $ 1171M 106M
Bristol Myers Squibb BMY:US $ 2695M 914M
Celldex Therapeutics CLDX:US $ 0.84M 0.15M
Chemocentryx CCXI:US $ 4.41M 6.68M
Dicerna Pharmaceuticals DRNA:US $ 8.32M 4.51M
Eli Lilly And LLY:US $ 1566.8M 31M
Flexion Therapeutics FLXN:US $ 7.49M 2.02M
Intrexon XON:US $ 3.62M 1.31M
Karyopharm Therapeutics KPTI:US $ 881K 1.43M
Kindred Biosciences KIN:US 926K 573K
Macrogenics MGNX:US $ 6.17M 3.65M
Mannkind MNKD:US $ 9.53M 2.04M
Minerva Neurosciences NERV:US $ 1.2M 0.39M
Newlink Genetics NLNK:US 149K 163K
Novartis NOVN:VX 4.66B 146M
Novavax NVAX:US $ 59.56M 14.43M
Peregrine Pharmaceuticals PPHM:US $ 10.01M 0.39M
Repligen RGEN:US $ 28.19M 3.29M
Xencor XNCR:US $ 9.13M 2.02M